Salt loading promotes kidney injury via fibrosis in young female ren2 rats

CardioRenal Medicine

Volumn 4, Issue 1, 2014, Pages 43-52

  Habibi, Javad ^a,b,d,e   Hayden, Melvin R ^a,b,d   Ferrario, Carlos M ^f   Sowers, James R ^a,b,c,d,e   Whaley Connell, Adam T ^a,b,d,e  

^a University of Missouri   (United States)

^b Departments of Internal Medicine Hepatology   (United States)

^c Medical Physiology and Pharmacology   (United States)

^d Divisions of Endocrinology and Metabolism   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Fibrosis; Proteinuria; Reactive oxygen species; Transgenic (mRen2)27 rat

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA; 3 NITROTYROSINE; ANGIOTENSIN 2 RECEPTOR; NITROGEN DERIVATIVE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; FEMALE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY STRUCTURE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROTEINURIA; RAT; SALT INTAKE; SALT LOADING; ALDOSTERONE BLOOD LEVEL; COMPARATIVE STUDY; DIASTOLIC DYSFUNCTION; DIET SUPPLEMENTATION; FIBROSING ALVEOLITIS; KIDNEY FUNCTION; KIDNEY PARENCHYMA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; TRANSGENIC RAT;

EID: 84897996023     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000360866     Document Type: Article

References (37)

1. Iseki K: Gender differences in chronic kidney disease. Kidney Int 2008; 74: 415-417.
2. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of non-diabetic renal disease: a metaanalysis. Am Soc Nephrol 2000; 11: 319-329. (Pubitemid 30064855)
3. Stanton RC, King GL: A complex interplay of factors causes diabetic nephropathy. Metabolism 2011; 60: 591-593.
4. Susic D, Frohlich ED: Hypertensive cardiovascular and renal disease and target organ damage: lessons from animal models. Cardiorenal Med 2011; 1: 139-146.
5. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis 2012; 60: 850-886.
6. Wolf G: Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 2006; 70: 1914-1919. (Pubitemid 44863378)
7. Hellmich B, Schellner M, Schatz H, Pfeiffer A: Activation of transforming growth factor-beta1 in diabetic kidney disease. Metabolism 2000; 49: 353-359. (Pubitemid 30146567)
8. Sun GP, Kohno M, Guo P, et al: Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol 2006; 17: 2193-2201. (Pubitemid 44141909)
9. Friedman SL, Sheppard D, Duffield JS, Violette S: Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 2013; 5: 167.
10. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC: Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003; 284:F955-F965. (Pubitemid 36443580)
11. Komukai K, Mochizuki S, Yoshimura M: Gender and the renin-angiotensin- aldosterone system. Fundam Clin Pharmacol 2010; 24: 687-698.
12. Johnson MS, DeMarco VG, Heesch CM, et al: Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat. Am J Physiol Heart Circ Physiol 2011; 301:H1540-H1550.
13. Cohen JA, Lindsey SH, Pirro NT, et al: Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain. Am J Physiol Renal Physiol 2010; 299:F35-F42.
14. Jones-Burton C, Mishra SI, et al: An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol 2006; 26: 268-275. (Pubitemid 44114397)
15. Blendea MC, Jacobs D, Stump CS, et al: Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. Am J Physiol Endocrinol Metab 2005; 288:E353-E359. (Pubitemid 40110643)
16. Whaley-Connell AT, Habibi J, Aroor A, et al: Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats. Metabolism 2013; 62: 1761-1771.
17. Habibi J, Hayden MR, Sowers JR, et al: Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats. Endocrinology 2011; 152: 659-668.
18. Kriz W, Kaissling B, Le Hir M: Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474.
19. Yamaleyeva LM, Pendergrass KD, Pirro NT, et al: Ovariectomy is protective against renal injury in the highsalt- fed older mRen2. Lewis rat. Am J Physiol Heart Circ Physiol 2007; 293:H2064-H2071. (Pubitemid 47605842)
20. Rands VF, Seth DM, Kobori H, Prieto MC: Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. Gend Med 2012; 9: 207-218.
21. Lindsey SH, Yamaleyeva LM, Brosnihan KB, et al: Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension 2011; 58: 665-671.
22. Aroor AR, McKarns S, Demarco VG, et al: Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 2013; 62: 1543-1552.
23. Pimenta E, Calhoun DA: Aldosterone, dietary salt, and renal disease. Hypertension 2006; 48: 209-210. (Pubitemid 44309812)
24. Brown NJ: Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol 2013; 9: 459-469.
25. Arias-Loza PA, Muehlfelder M, Elmore SA, et al: Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease. Toxicol Pathol 2009; 37: 969-982.
26. Luther JM, Luo P, Wang Z, et al: Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int 2012; 82: 643-651.
27. Iwano M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 279-284. (Pubitemid 38582300)
28. Rodrguez-Iturbe B, Garca Garca G: The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 2010; 116:c81-c88.
29. Hewitson TD: Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 2009; 296:F1239-F1244.
30. Zeisberg EM, Potenta SE, Sugimoto H, et al: Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-2287.
31. Lastra G, Santos FR, Hooshmand P, Hooshmand P, Mugerfeld I, Aroor AR, Demarco VG, Sowers JR, Henriksen EJ: The novel angiotensin II receptor blocker azilsartan medoxomil ameliorates insulin resistance induced by chronic angiotensin II treatment in tat skeletal muscle. Cardiorenal Med 2013; 3: 154-164.
32. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor. J Clin Invest 1993; 92: 1366-1372. (Pubitemid 23273912)
33. Hovater MB, Sanders PW: Effect of dietary salt on regulation of TGF-? in the kidney. Semin Nephrol 2012; 32: 269-276.
34. Juknevicius I, Segal Y, Kren S, et al: Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol 2004; 286:F1059-F1062. (Pubitemid 38656360)
35. Kim S, Ohta K, Hamaguchi A, et al: Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994; 24: 195-204.
36. Hills CE, Squires PE: TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 2010; 31: 68-74.
37. Hayden MR, Sowers KM, Pulakat L, Joginpally T, Krueger B, Whaley-Connell A, Sowers JR: Possible mechanisms of local tissue renin-sngiotensin system activation in the cardiorenal metabolic syndrome and type 2 diabetes mellitus. Cardiorenal Med 2011; 1: 193-210.